Economic evaluation of oxytocin in Uniject model web-based The Institute for Clinical Effectiveness and Health Policy (IECS), the Pan American Health Organization (PAHO/WHO), and the USAID Bureau for Global Health’s flagship maternal, neonatal and child health program, the Maternal and Child Health Integrated Program (MCHIP) made an economic evaluation of oxytocin in Uniject™ injection system versus standard use of oxytocin for the prevention of postpartum hemorrhage in the active management of the third stage of labor in Latin America and the Caribbean. To access the full version of the report click here. To enable decision makers and researchers in each country to gauge the economic model to their context, allowing the possibility of selecting new values for the various parameters thus obtaining results that better reflect the local reality of their country or region the tool below was built. To access the economic model, click here
